What university do you go to? homework writing services Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group(TM), with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that Diagnoplex has secured 1.3 million Swiss francs from a financing round led by Debiopharm. 必須 2000文字以内 [bbs:youtube:(Youtubeの動画ID)]と書くとYoutubeの動画が貼れます。(例:[bbs:youtube:OQThUAQ0UN0])